Global DNA Microarray Market - 2023-2030
Global DNA Microarray Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX % during the forecast period 2023-2030.
The DNA microarray is a tool used to determine whether the DNA from a particular individual contains a mutation in genes like BRCA1 and BRCA2. The chip consists of a small glass plate encased in plastic. Some companies manufacture microarrays using methods similar to those used to make computer microchips. DNA microarrays are used in clinical diagnostic tests for some diseases. Sometimes they are also used to determine which drugs might be best prescribed for particular individuals because genes determine how our bodies handle the chemistry related to those drugs.
Market Dynamics: Drivers and Restraints
Rise in strategic initiatives by the key players
Partnerships and collaborations to develop precision medicine and genotyping capabilities are among the strategic activities done by the leading competitors and are projected to provide attractive opportunities for expansion for the market.
For instance, in May 2022, Qatar Genome Program and Thermo Fisher Scientific announced a partnership to accelerate genomic research and clinical applications of predictive genomics in Qatar. This partnership expanded the advantages of precision medicine across the Middle East. Moreover, it comprises custom genotyping arrays designed to boost clinical applications of predictive genomics.
Furthermore, the DNA microarray market is also driven by various other factors like the rising prevalence of cancer, the rapidly evolving information & software technology, and emerging bioinformatics are the factors likely to drive the global DNA microarray market. In addition, the surge in research activities and the rising use of DNA microarray in gene expression fuel the global market growth.
Market Dynamics: Restraint
One of the significant restraints hampering the growth of the market is the high cost associated with DNA sequencing. While DNA microarrays offer valuable insights into gene expression and genetic variations, the expenses incurred during sequencing procedures can be substantial. This cost comprises not only the acquisition of the microarray technology itself but also the expenses related to sample preparation, data analysis and maintenance of sophisticated equipment.
Segment Analysis
The global DNA Microarray market is segmented based on product type, type, application, end-user and region.
The Consumables from the product type segment accounted for approximately 43.5% of the DNA Microarray market share
The consumables from the product type segment accounted for approximately 43.5% and is expected to dominate during the forecast period. The consumables play a crucial role in DNA microarray experiments. This segment includes various components necessary for DNA microarray experiments, such as arrays, reagents, buffers, and other essential consumables. These consumables are vital for the success of the experiments and are used in processes such as printing DNA microarray slides, hybridization, and fluorescence-based detection systems.
Geographical Analysis
North America accounted for approximately 38.4% of the market share in 2022
North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the presence of leading market players in the region and rising investments by them in developing technologically advanced DNA microarray products.
Moreover, technological advancements in genomics and access to modern research facilities are likely to create exponential growth opportunities for the players. Also, the high adoption of DNA microarray technology across research settings, from academic laboratories to biopharmaceutical companies, is further escalating the region’s growth.
For instance, in January 2023, the NCBI announced the development of a microarray system to detect UDP-glucuronosyltransferase gene polymorphisms for use in clinical laboratories in patients eligible for irinotecan hydrochloride treatment. It allows the construction of a measurement system for high-density and DNA fixation clinical applications.
COVID-19 Impact Analysis
The COVID-19 pandemic had a positive impact on the global DNA/gene microarray market, owing to increased research and development activities using arrays in the treatment of patients suffering from COVID-19.
Market Segmentation
By Product Type
• Consumables
• Instruments
• Kits
By Type
• Complementary DNA microarrays
• Oligo DNA microarrays
• BAC microarrays
• SNP microarrays
By Application
• Gene Expression Analysis
• Genotyping
• Transcription Factor Binding Analysis
• Others
By End User
• Pharmaceutical and Biotechnology Companies
• Diagnostic Centers
• Hospitals
• Others
By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Thermo Fisher Scientific Inc., QIAGEN, Illumina, Inc., Agilent Technologies, Inc., Arrayit Corporation, PerkinElmer, Inc., Toray Group, Microarrays Inc., Twist Bioscience Corporation, Arraylt Corporation among others.
Key Developments
On January 15, 2023, National Center for Biotechnology Information, announced the development of a microarray system to detect UDP-glucuronosyltransferase gene polymorphisms for use in clinical laboratories in patients eligible for irinotecan hydrochloride treatment. It allows the construction of a measurement system for high-density and DNA fixation clinical applications.
In May 2022, Qatar Genome Program, a research institute, and Thermo Fisher Scientific, a provider of diagnostic solutions, announced a partnership to accelerate genomic research and clinical applications of predictive genomics in Qatar.
Why Purchase the Report?
• To visualize the global DNA microarray market segmentation based on product type, type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of DNA microarray market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global DNA microarray market report would provide approximately 69 tables, 70 figures and 183 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
- 1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
- 2. Definition and Overview
- 3. Executive Summary
- 3.1. Snippet by Product Type
- 3.2. Snippet by Type
- 3.3. Snippet by Application
- 3.4. Snippet by End User
- 3.5. Snippet by Region
- 4. Market Dynamics
- 4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Rise in strategic initiatives by the key players
- 4.1.1.2. Rise in the advancement in DNA microarrays
- 4.1.2. Restraints
- 4.1.2.1. High cost associated with the DNA sequencing
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
- 5. Industry Analysis
- 5.1. Porter's Five Force Analysis
- 5.2. Supply Chain Analysis
- 5.3. Pricing Analysis
- 5.4. Regulatory Analysis
- 5.5. Unmet Needs
- 5.6. DMI Opinion
- 6. COVID-19 Analysis
- 6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
- 6.2. Pricing Dynamics Amid COVID-19
- 6.3. Demand-Supply Spectrum
- 6.4. Government Initiatives Related to the Market During Pandemic
- 6.5. Manufacturers Strategic Initiatives
- 6.6. Conclusion
- 7. By Product Type
- 7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
- 7.2. Consumables*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.3. Instruments
- 7.4. Kits
- 8. By Type
- 8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 8.1.2. Market Attractiveness Index, By Type
- 8.2. Complementary DNA microarrays*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 8.3. Oligo DNA Microarrays
- 8.4. BAC microarrays
- 8.5. SNP microarrays
- 9. By Application
- 9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
- 9.2. Gene Expression Analysis*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.3. Genotyping
- 9.4. Transcription Factor Binding Analysis
- 9.5. Others
- 10. By End User
- 10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.1.2. Market Attractiveness Index, By End User
- 10.2. Pharmaceutical and Biotechnology Companies*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 10.3. Diagnostic Centers
- 10.4. Hospitals
- 10.5. Others
- 11. By Region
- 11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
- 11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.2.7.1. U.S.
- 11.2.7.2. Canada
- 11.2.7.3. Mexico
- 11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.3.7.1. Germany
- 11.3.7.2. UK
- 11.3.7.3. France
- 11.3.7.4. Italy
- 11.3.7.5. Spain
- 11.3.7.6. Rest of Europe
- 11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.4.7.1. Brazil
- 11.4.7.2. Argentina
- 11.4.7.3. Rest of South America
- 11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.5.6.1. China
- 11.5.6.2. India
- 11.5.6.3. Japan
- 11.5.6.4. Australia
- 11.5.6.5. Rest of Asia-Pacific
- 11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 12. Competitive Landscape
- 12.1. Competitive Scenario
- 12.2. Market Positioning/Share Analysis
- 12.3. Mergers and Acquisitions Analysis
- 13. Company Profiles
- 13.1. Thermo Fisher Scientific, Inc*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
- 13.2. QIAGEN
- 13.3. Illumina, Inc
- 13.4. Agilent Technologies, Inc
- 13.5. Arrayit Corporation
- 13.6. PerkinElmer, Inc
- 13.7. Toray Group
- 13.8. Microarrays Inc
- 13.9. Twist Bioscience Corporation
- 13.10. Arraylt Corporation
- LIST NOT EXHAUSTIVE
- 14. Appendix
- 14.1. About Us and Services
- 14.2. Contact Us
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook